Approvals/CIMA-AEMPS/EPIRUBICINA HIKMA 2 MG/ML SOLUCION INTRAVESICAL E INYECTABLE EFG

Approved

STANDARD

EPIRUBICINA HIKMA 2 MG/ML SOLUCION INTRAVESICAL E INYECTABLE EFG

Hikma Farmaceutica (Portugal) S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 9b9389c5400a00eb
Drug Cima Aemps Name: EPIRUBICINA HIKMA 2 MG/ML SOLUCION INTRAVESICAL E INYECTABLE EFG
Register Number: 85307
Holder Company Name: Hikma Farmaceutica (Portugal) S.A.
Marketing Company Name: Hikma España, S.L.U.
Holder Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a
Authorization Date: 2023-02-22
Dosage Form: SOLUCION INTRAVESICAL E INYECTABLE
Dose: 2 mg/ml
Route Of Administration: VÍA INTRAVENOSA, VÍA INTRAVESICAL
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Hikma Farmaceutica (Portugal) S.A.
Company Detail Path: /organization/hikma-farmaceutica-portugal-s-a

EPIRUBICINA HIDROCLORURO

2 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 22, 2023

Approval ID

9b9389c5400a00eb

Type

Standard